Welcome to our dedicated page for Agronomics news (Ticker: AGNMF), a resource for investors and traders seeking the latest updates and insights on Agronomics stock.
Agronomics Limited (AGNMF) is a London-listed investment company focused on clean food and cellular agriculture, and its news flow reflects activity across a portfolio of more than 20 private companies in this emerging field. Company announcements cover new investments, follow-on funding, portfolio milestones and periodic updates on net asset value, giving readers insight into how Agronomics is deploying capital and how its holdings are progressing.
Recent news has highlighted additional investments in precision fermentation businesses, such as funding for All G Co Holdings Pty Limited, which develops human and bovine milk proteins like lactoferrin without the use of animals. Agronomics has also reported further equity investment in BlueNalu, Inc., a cell-cultivated seafood company working on products such as cultivated bluefin tuna toro for premium foodservice markets.
Updates on other portfolio companies include Liberation Bioindustries, which is building a commercial-scale precision fermentation facility to produce bio-based protein and other ingredients, Geltor, Inc., which has received an FDA “no questions” letter confirming GRAS status for its vegan collagen polypeptide PrimaColl, Clean Food Group Limited, which manufactures sustainable oils and fats through fermentation, and Onego Bio, whose precision-fermented egg protein Bioalbumen has also received an FDA GRAS “no questions” letter.
News items may also cover less favourable developments, such as the dissolution of Meatable B.V., and periodic net asset value calculations that summarise the impact of portfolio movements and foreign exchange changes on Agronomics’ balance sheet. For investors and observers interested in cellular agriculture and alternative proteins, the Agronomics news stream provides regular, company-sourced updates on financing rounds, regulatory progress and commercial partnerships across this specialised investment portfolio.
Agronomics (LSE:ANIC) announces that its portfolio company, Onego Bio, has secured EUR 14 million in new funding from the European Innovation Council Accelerator Program and an additional Series A investor. This brings Onego's total funding to EUR 65 million. Agronomics' investment in Onego remains at EUR 8.4 million, currently valued at GBP 11.1 million (EUR 12.9 million), accounting for 6.7% of Agronomics' last published Net Asset Value. Agronomics holds a 16.1% equity ownership on a fully diluted basis.
Onego Bio, a precision fermentation company, is developing Bioalbumen®, a bio-identical egg protein. The company aims to commercialize in North America first, with plans to submit a GRAS notice to the FDA this year. The new funding will support Onego's go-to-market plans in both the US and EU, including regulatory approval processes.
Agronomics, a London-listed cellular agriculture company, announced the exercise of warrants, resulting in the issuance of 1,791 Ordinary Shares at 28.5p each, generating gross proceeds of £510.43. These shares will be admitted to trading on AIM around June 11, 2024, and will be pari passu with existing shares. Following this admission, Agronomics' total share count will be 1,009,411,583. Shareholders can use this updated share count for transparency rule calculations. Agronomics has a portfolio of over 20 companies focused on innovative food and material production technologies, addressing sustainability, human health, animal welfare, and environmental issues.
Agronomics announced an unaudited Net Asset Valuation per share of 16.98 pence, a 0.5% increase from the previous quarter. The company's Net Assets were £171 million, with a 48% discount to the share price. Agronomics made progress in funding rounds and partnerships, marking positive revaluations and acquisitions within their portfolio.
Agronomics , a leading company in cellular agriculture, announces that its portfolio company Meatly has developed a protein-free culture medium for cultivated meat at a groundbreaking price of one pound per liter. This innovation significantly reduces production costs and paves the way for price parity with conventional meat products. With a focus on the pet food market, Meatly's achievement marks a critical milestone in the cultivated meat industry, driving scalability and affordability. Agronomics and investors like Pets at Home are supporting Meatly's upcoming product release, highlighting the company's positive trajectory in the alternative proteins sector.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.